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During inflammatory reaction, neutrophils exhibit numerous cellular and immunological 
functions, notably the formation of neutrophil extracellular traps (NETs) and autophagy. 
NETs are composed of decondensed chromatin fibers coated with various antimicrobial 
molecules derived from neutrophil granules. NETs participate in antimicrobial defense 
and can also display detrimental roles and notably trigger some of the immune features 
of systemic lupus erythematosus (SLE) and other autoimmune diseases. Autophagy is a 
complex and finely regulated mechanism involved in the cell survival/death balance that 
may be connected to NET formation. To shed some light on the connection between 
autophagy and NET formation, we designed a number of experiments in human neu-
trophils and both in normal and lupus-prone MRL/lpr mice to determine whether the 
synthetic peptide P140, which is capable of selectively modulating chaperone-medi-
ated autophagy (CMA) in lymphocytes, could alter NET formation. P140/Lupuzor™ is 
currently being evaluated in phase III clinical trials involving SLE patients. Overall our 
in  vitro and in  vivo studies established that P140 does not influence NET formation, 
cytokine/chemokine production, or CMA in neutrophils. Thus, the beneficial effect of 
P140/Lupuzor™ in SLE is apparently not directly related to modulation of neutrophil 
function.
Keywords: neT formation, neutrophils, autophagy, murine models of lupus, systemic lupus erythematosus, P140/
lupuzor
inTrODUcTiOn
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by chronic 
reactivity against components of the cell nucleus that results in the formation of antinuclear 
autoantibodies and multiorgan involvement. It is thought that the immune system in lupus is 
sensitized to intracellular antigens following extended exposure to chromatin under inflamma-
tory conditions. This can be caused by insufficient removal of cells having undergone apoptosis 
or the formation of neutrophil extracellular traps (NETs) (1–3). NETs contain a complex network 
made of processed chromatin bound to granular and selected cytoplasmic proteins. Due to the 
large amounts of nuclear antigens freely accessible in NETs, they are prime candidates for the 
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initiation or enhancement of autoimmunity and organ damage 
in lupus (4). Blockade of NET formation by pharmacological 
inhibition of peptidylarginine deiminases, which are essential 
for certain forms of NET formation (5), is therefore considered 
a promising strategy to ameliorate the clinical course of SLE 
(6, 7).
There is currently no cure for lupus but in the list of molecules 
that show clear benefits in patients with SLE are antimalarials, 
such as hydroxychloroquine/Plaquenil™, a therapeutic that 
is generally prescribed in combination with steroids or other 
compounds. This molecule, which unfortunately induces 
undesirable side effects that can be dramatic (retinopathy), 
directly influences lysosomal pathways. Other drugs acting at 
the level of the lysosome through known or assumed modula-
tion of autophagic pathways include rapamycin, bortezomib/
Velcade™ (8), 15-deoxyspergualin/Gusperimus™ that how-
ever displays serious adverse effects (most notably leukopenia), 
and P140/Lupuzor™ (9–11). The P140 peptide was shown to 
ameliorate lupus in the MRL/lpr murine model of the disease 
and to significantly delay mortality (12, 13). Moreover, treat-
ment of patients with SLE with P140/Lupuzor™ convincingly 
improved the biological and clinical status of patients in a 
multicenter, randomized, placebo-controlled phase IIb trial 
and was considered efficacious and safe for the treatment of 
SLE (14). P140/Lupuzor™ recently entered into multicenter, 
double-blind, placebo-controlled phase III clinical trials in 
the US, Europe, and countries of the West Indian Ocean. The 
21-mer peptide P140 encompasses residues 131–151 of the 
spliceosomal U1-70K protein, containing a phosphoserine 
at position 140 (hence its name). In MRL/lpr mice, P140 
was shown to work via inhibition of autophagy, particularly 
chaperone-mediated autophagy (CMA), which we discovered 
to be hyperactivated in lymphocytes in this mouse model (10, 
11, 15). In the lysosomes of MRL/lpr B cells, the phosphoryl-
ated peptide P140, but interestingly not the non-protective 
unphosphorylated peptide (termed 131-51), is supposed to 
compromise CMA by disruption of the lumenal HSPA8 het-
erocomplexes containing HSP90 as it does in vitro (11). This 
inhibitory effect on CMA modulates autoantigen loading to 
MHCII molecules and therefore results in a diminished prim-
ing of autoreactive T cells. Consequentially, the proliferation 
of autoreactive B cells and their differentiation into deleterious 
autoantibody-secreting plasma cells is reduced.
Previous studies have stated that phorbol myristate acetate 
(PMA)-induced formation of NETs requires autophagy (16). 
Autophagy was also claimed to be involved in various neutrophil 
functions and in neutrophil-mediated inflammation (17, 18). 
We therefore wondered whether the effect of P140/Lupuzor™ 




P140, scrambled P140 (ScP140), and the non-phosphorylated 
peptide 131-151 were synthesized and purified as described 
previously (19). Homogeneity of peptides was checked by analyti-
cal high-performance liquid chromatography, and their identity 
was assessed by MALDI-TOF mass spectrometry.
Mice
C3H/HeOuJ (thereafter named C3H) and MRL/MpJ-Faslpr/2J 
(thereafter named MRL/lpr) mice were bought from Charles 
River. MRL/lpr mice were also kindly given by Prof. Lars 
Nitschke, Division of Genetics, Department of Biology, 
Erlangen-Nuremberg University. Mice were kept at 12 h light/
dark cycles in polystyrene cages in the animal facilities of the 
University of Erlangen-Nuremberg and CNRS in Strasbourg 
and were fed with standard rodent chow and water ad libitum. 
Experiments, which were performed with the investigators 
blinded to group allocation, were approved by the local ethi-
cal committees (Regierung von Unterfranken, Germany, and 
Comité Régional d’Ethique en Matière d’Expérimentation 
Animale de Strasbourg, respectively).
In Vivo Treatment with Peptides
P140, ScP140, and 131-51 peptides were resuspended in distilled 
water to a concentration of 10  mg/mL and further diluted in 
0.9% (w/v) NaCl to a concentration of 100  µg/100  µl. Each 
mouse received two intravenous injections of 100  µg P140 or 
control peptides at days 1 and 4. Twenty-four hours after the last 
injection, blood was collected in heparinized collection tubes 
(Sarstedt) and processed and described as below.
isolation of human and Mouse  
neutrophils
A total of 20 mL heparinized blood were taken from each human 
normal healthy donor. A total of 15 mL of phosphate-buffered 
saline (PBS) without calcium and magnesium (Thermo Fisher 
Scientific) were added and polymorphonuclear leukocytes 
(PMNs) were isolated by standard density gradient centrifugation 
using Ficoll (Bio-Rad). To remove contaminating erythrocytes, 
PMNs were subjected to short cycles of hypotonic lysis with 
deionized water. Finally, PMNs were adjusted to a concentration 
of 2  ×  106  cells/mL in PBS without calcium and magnesium 
(Thermo Fisher Scientific).
For isolation of mouse neutrophils, single-cell suspensions 
were prepared from spleens of mice by squeezing through a 70 µm 
cell strainer. After hypotonic lysis of erythrocytes, neutrophils 
were isolated by negative selection using the EasySep™ mouse 
neutrophil enrichment kit (Stemcell Technologies) according to 
the manufacturer’s instruction.
Purity of isolated neutrophils was checked by flow cytometry 
and was above 95% (human neutrophils) or 85% (mouse neutro-
phils), respectively. All experiments were approved by the ethical 
committee of the University of Erlangen-Nuremberg.
Plate reader-Based Quantification  
of neT Formation
Isolated neutrophils were adjusted to a concentration of 
2 × 106 cells/mL in Hanks’ balanced salt solution (HBSS; Thermo 
FigUre 1 | no influence of P140 or the control peptides scrambled P140 (scP140) and 131-51 on neutrophil extracellular trap (neT) formation or 
production of reactive oxygen species (rOs) or cytokines/chemokines in human PMn. (a) Kinetics of relative SYTOX Green fluorescence in isolated human 
PMN after incubation with or without 100 ng/mL PMA. Graphs show data from one representative out of three normal healthy blood donors. (B) Intracellular ROS 
production or (c) cytokine/chemokine release into the supernatants upon incubation of isolated human PMN with varying concentrations of P140 or the control 
peptides ScP140 or 131-151. Baseline values of vehicle-treated neutrophils are subtracted. Bars in (c) show the means and SD of one representative out of two 
experiments.
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Fisher Scientific). Cell suspension (100 µL) was pipetted into each 
well of a 96-well cell plate. A total of 100 μL of HBSS and 5 µM 
Sytox Green (Thermo Fisher Scientific) containing either PMA 
(200  ng/mL; Sigma), ionomycin (2  µg/mL; Sigma), or vehicle 
control were added to the cells. The plate was tightly sealed and 
analyzed in an infinite® 200 pro plate reader (TECAN). Relative 
fluorescence units were normalized to the starting values and the 
respective vehicle control.
FigUre 2 | Plate reader-based quantification of neutrophil extracellular trap formation in mice treated with P140 and scrambled P140 (scP140). 
(a) Relative SYTOX Green fluorescence in neutrophils isolated from the blood of P140- or ScP140-pretreated mice incubated for 2 h with or without 100 ng/mL 
PMA or 2 µg/mL ionomycin. Graphs show individual values and means, one dot represents one mouse. ns, not significant. (B) Area and fluorescence intensity of 
SYTOX Green+ events in neutrophils isolated from the blood of P140- or ScP140-pretreated mice incubated for 2 h with or without 100 ng/mL PMA or 2 µg/mL 
ionomycin. Plots show medians and individual values from one representative out of 6–8 mice. ***p < 0.001, as determined by Student’s t-test with Bonferroni 
post hoc test. ns, not significant.
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immunohistochemical analysis of neT 
Formation
Isolated neutrophils were adjusted to a concentration of 
2 × 106 cells/mL in HBSS containing calcium and magnesium. 
A total of 100 μL of cell suspension was added to each well of 
an 8-well cell chamber slide (Thermo Fisher Scientific). A total 
of 100 μL of HBSS containing either 200 ng/mL PMA, 2 µg/mL 
ionomycin, or vehicle control were added to the cells. The cham-
ber slide was incubated at 37°C and 5% CO2 for 2 h. Subsequently, 
1% (v/v) paraformaldehyde (Merck) was added to each well and 
the preparations incubated for 18 h at 4°C. Samples were blocked 
with 10% (v/v) fetal calf serum (FCS; Biochrome)/2% (w/v) 
bovine serum albumin (BSA) in PBS for 1 h at room tempera-
ture. Primary antibody for neutrophil elastase (NE) (Abcam ref. 
ab21595; 1:200) or citrullinated histone H3 (Abcam ref. ab1503; 
1:100) were added in 10% FCS/2% BSA in PBS for 18 h at 4°C. 
Slides were washed three times with PBS and secondary Cy5-
conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch) 
was added for 1.5 h at room temperature in the dark. Slides were 
washed with PBS. Staining solution containing 2.5 µM SYTOX 
Green in PBS was added for 15 min at room temperature. Slides 
were washed with H2O and samples were embedded in mount-
ing medium (BIOZOL). Slides were analyzed the same day on 
a BZ-X710 microscope (Keyence). Events positive for SYTOX 
Green were analyzed with regard to area and mean intensity by 
Photoshop CS5 software. Percentage of NETs was defined as PI/
NE double-positive events with >3-fold mean nuclear size on 
three random slide sections.
analysis of autophagy
Spleens were homogenized through a 70  µM strainer, washed, 
and seeded at a concentration of 4 × 106 cells/well in a 48-well 
plate with 1  mL of complete culture media in the presence or 
absence of lysosomal protein inhibitors pepstatin A (5  µg/mL; 
ref. P5318; Sigma) and E64d (5 µg/mL; ref. E8640; Sigma). After 
4 h at 37°C under 5% CO2, cells were washed, lysed by adding 
160 µL/sample of Laemmli buffer (ref. 161-0737; Bio-Rad) con-
taining 5% (v/v) β-mercaptoethanol, and finally boiled at 95°C 
FigUre 3 | Morphological analysis and quantification of neutrophil extracellular traps (neTs) in P140 and scrambled P140 (scP140)-treated mice by 
fluorescence microscopy. Representative immunofluorescence images of SYTOX Green-, neutrophil elastase (NE)-, and citrullinated histone H3 (citH3)-stained 
neutrophils isolated from ScP140- (a–c) and P140- (D–F) treated mice and incubated without external stimulus (a,D), with PMA (B,e) or with ionomycin (c,F). Left 
panels show staining controls incubated without (wo) primary antibody to NE or citH3. CY5 stands for control Cyanin 5 and OL stands for overlay. (g) Quantitative 
analysis of NETs. Scatter plots show individual values and mean of %NETs (defined as % PI+/NE+ cells with >3-fold mean nuclear size) from two mice.
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FigUre 4 | analysis of neutrophil extracellular trap formation in 
starved c3h and in Mrl/lpr mice treated with P140, scrambled P140 
(scP140), or 131-151 peptides. Neutrophils were isolated from the blood of 
C3H mice starved for 36 h (a) or MRL/lpr mice (B) pretreated with with 
injections of P140, ScP140, or the non-phosphorylated peptide 131-151 and 
incubated with SYTOX Green and with or without 100 ng/mL PMA. Graphs 
show individual values and means of relative SYTOX fluorescence after 2 h 
incubation (a) or 2 and 4 h incubation (B), respectively, normalized to starting 
values. One symbol represents one mouse. n = 3–8.
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(5 min) before loading (20 µL samples, equivalent to 0.5 × 106 
cells) on 4–20% SDS-PAGE gradient gels for analysis. For west-
ern immunoblotting, the following antibodies were used: rabbit 
SQSTM1/p62 (0.5 µg/mL; ref. ab109012), rabbit HSPA8 (0.5 µg/
mL; ref. ab51052), and rabbit ATG12/5 (ref. ab155589), all from 
Abcam, and mouse microtubule-associated-protein light chain 
3b (MAP1LC3B) (0.5 µg/mL; ref. M186-3) from MBL. Secondary 
antibodies were peroxidase-conjugated goat anti-mouse IgG 
Fc (50  ng/mL; ref. 115-035-008) and goat anti-rabbit IgG Fc 
(25  ng/mL; ref. 111-035-008) from Jackson ImmunoResearch. 
ACTB-reacting antibodies were from Santa Cruz (10 ng/mL; ref. 
sc47778).
Measurement of reactive Oxygen species 
(rOs) and inflammatory Mediators
For measurement of ROS in human PMNs, lithium-heparinized 
blood was incubated with dihydrorhodamine 123 (3  µg/mL, 
Molecular Probes) for 15 min at 37°C. Cells were then stained 
with anti-human CD14-eFluor450 and CD16-APC/Cy7, and 
ROS production was measured after incubation with peptides 
(10, 20, or 30  µM) or PMA (100  ng/mL) for 15  min at 37°C. 
Before analysis on a Beckman Coulter Gallios™, FACS samples 
were subjected to hypotonic water lysis.
Cytokines/chemokines in supernatants of human PMNs after 
18 h incubation with varying concentrations of peptides, 2.5 µg/
mL LPS, or 1  µM ionomycin in RPMI medium including 1% 
autologous serum were analyzed by Legendplex bead technol-
ogy (BioLegend) and quantified on a Gallios™ cytofluorometer 
(Beckman Coulter).
statistical analysis
For calculation of statistical differences, we used Mann–Whitney 
U test or unpaired Student’s t-test with Welch’s correction, 
Dunnett’s, or Bonferroni’s post hoc test, where applicable. Adjusted 
p <  0.05 was considered statistically significant. Computations 
and charts were performed using the GraphPad Prism 6 software.
resUlTs
To investigate a potential direct effect of P140 on NET formation, 
we pre-incubated isolated human PMNs with increasing concen-
trations of P140 or control ScP140 peptide (10–30 µM) for 1 h 
and measured SYTOX Green fluorescence after treatment with 
the NET-inducing agent PMA. The concentrations of peptides 
used for incubation have been previously shown not to be toxic 
to cells, except that prolonged incubation with concentrations 
over 20 µM induces granzyme B-dependent apoptosis in specific 
T cell subsets (13). Quantitative analysis of NET formation was 
performed in an established plate reader-based assay. Treatment 
with P140 or ScP140 did not reveal any effect on the capacity 
of PMNs to undergo NETosis in response to PMA (Figure 1A). 
Also neither P140 nor ScP140 directly induced NET formation, 
production of ROS, or cytokine/chemokine production in these 
cells (Figures 1B,C).
Isolated PMNs have a very limited lifespan, which precludes 
extended in  vitro treatment with P140. To overcome this 
limitation, we administered two intravenous doses of 100 µg P140 
or ScP140, respectively, into mice and sacrificed the mice 1 day 
later. Injections were performed in C3H mice because this strain 
harbors elevated number of neutrophils in the circulation (20), 
which resembles the human situation more closely than other 
mouse strains. Neutrophils from the blood were then purified 
from P140/ScP140-treated mice and NET formation was induced 
with PMA and ionomycin, respectively. Injection of P140 did not 
significantly influence the amount of total SYTOX fluorescence 
(Figure  2A). Also the mean area or fluorescence intensity of 
SYTOX Green+ events was not significantly different between 
cells isolated from P140 and ScP140-treated mice (Figure 2B).
SYTOX Green detects extracellular DNA, which can occur 
in NETs and other forms of cell death (21). However, DNA 
FigUre 5 | effect of P140 peptide on autophagic flux evaluated by measuring MaP1lc3B-ii levels in total splenocytes from non-starved mice and 
starved c3h mice and Mrl/lpr mice. Cell lysates were resolved by SDS-PAGE, transferred onto polyvinylidene difluoride membranes before staining with 
anti-microtubule-associated-protein light chain 3b (MAP1LC3B) antibodies. When indicated, cells were treated (+) or not (−) during the last 4 h of the culture with 
5 µg/mL pepstatin A and 5 µg/mL E64d to block lysosomal degradation. (a) MAP1LC3B-II levels were evaluated by densitometry and normalized to ACTB/β-actin. 
Histogram bars represent the means of individual experiments with SEM. *p < 0.05, using a Mann–Whitney U test to compare the data obtained in the presence or 
absence of protease inhibitors. (B) Representative immunoblot. ACTB was used as loading controls. (c) Autophagic flux as measured by comparing values of 
MAP1LC3B-II in the presence of lysosomal protease inhibitors divided by values of MAP1LC3B-II in the absence of lysosomal protease inhibitors. Histogram bars 
represent the means of individual experiments with SEM. *p < 0.05 using a Mann–Whitney test between the untreated and treated mice, in each condition. The 
groups were constituted of n = 6 for non-starved C3H mice, n = 4 for starved C3H mice, and n = 5 for MRL/lpr mice.
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released during necrosis and other forms of cell death is not 
normally associated with material from neutrophil granules. 
NETs are defined by co-localization of nuclear content with 
granule proteins, such as myeloperoxidase, NE, or antimicro-
bial molecules (22). Furthermore, the citrullination of histones 
is typical for NET formation in response to some but not all 
triggers (5, 23, 24). We therefore performed a more thorough 
investigation of the morphological changes in PMA- and 
ionomycin-stimulated and unstimulated cells in neutrophils 
from mice pretreated with P140 or ScP140. This study was con-
ducted by immunofluorescence microscopy for SYTOX Green, 
NE, and citrullinated histone H3. Irrespective of the marker 
that was followed, no significant differences were observed 
between the groups of C3H mice that had received the P140 
and ScP140 peptides (Figure 3). Taken together, these results 
show that treatment with P140 does not affect NET formation 
in normal mice.
P140 has been previously shown to be active under conditions 
of increased autophagic flux (11, 15). Autophagy is activated 
in response to nutrient deprivation in almost all cell types. We 
therefore analyzed the effect of P140 in starved C3H mice. Again, 
NET formation was not significantly influenced upon injection of 
P140, ScP140, or non-phosphorylated peptide 131-51, as deter-
mined by plate reader-based fluorescence assay (Figure 4A) and 
morphology of immunofluorescence images of isolated mouse 
neutrophils (not shown).
FigUre 6 | effect of P140 peptide on autophagy evaluated by 
measuring sQsTM1, aTg12/5, and hsPa8 levels in total splenocytes 
from non-starved mice, starved c3h mice, and Mrl/lpr mice. Three 
markers were followed, namely, (a) SQSTM1, (B) ATG12/5, and (c) HSPA8. 
The groups were constituted of n = 6 for non-starved C3H mice, n = 4 for 
starved C3H mice, and n = 5 for MRL/lpr mice. Histogram bars represent the 
means of individual experiments with SEM. *p < 0.05 using a Mann–Whitney 
test between the untreated and treated mice, in each condition.
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So far, none of our data indicated that the ameliorative effect 
of P140/Lupuzor™ observed in patients with SLE and lupus mice 
could be related to the inhibition of NET formation. However, we 
had not yet looked at the influence of P140 under conditions of 
established lupus disease. We therefore analyzed NET formation 
in P140- and control peptide-treated MRL/lpr mice. Again no 
differences could be seen between MRL/lpr mice treated with 
P140, ScP140, or 131-151 peptides (Figure 4B).
The above data show no obvious evidence that the P140 
peptide might directly influence neutrophils to undergo NET 
formation. We then investigated further the effect of P140 pep-
tide on autophagy processes. The autophagic flux was measured 
by visualizing the expression of a well-established autophagy 
marker, namely, ATG8/MAP1LC3B, in calibrated conditions, in 
the presence or absence of lysosome proteases E64d and pepstatin 
A as described (25). We confirmed the existence of an active 
autophagic flux in total splenocytes of normal C3H mice, which 
however, was not altered by P140 peptide (Figures 5A–C, left). 
In spleen cells from starved C3H mice, however, no active flux 
was detectable and as expected, therefore, there was no signifi-
cant effect of P140 peptide (Figures 5A–C). The same result as 
shown with cells from starved C3H mice was observed in MRL/
lpr (activated) splenocytes (Figures 5A–C, right). For the same 
reasons, no statistically significant effect of P140 peptide was 
visualized when other markers of macroautophagy and CMA, 
such as ATG12/5 (that participates to the autophagosome forma-
tion), the autophagy substrate SQSTM1/p62, and the heat shock 
protein HSPA8, were followed in the whole splenocyte popula-
tion (Figures 6A–C).
The results generated with normal C3H splenocytes, in which 
autophagic flux is active and showing no effect of P140 peptide, 
probably result from the fact that in normal (unstressed) cells, 
the peptide entry notably differs from the one it uses in activated/
stressed cells and could not reach the cell compartment where it 
exerts its function (11).
The absence of P140 effect in total splenocytes from 16-week-
old diseased MRL/lpr mice contrasts with earlier results generated 
with B cells that were purified from the spleen of young (8-week-
old) MRL/lpr mice (15). In B cells, P140 could effectively reduce 
the excessive autophagic flux. To investigate if P140 influences 
autophagy directly in neutrophils, we isolated splenic neutrophils 
from MRL/lpr mice treated with either 100 µg P140 or ScP140 
(Figure 7). Interestingly, and in contrast to what was previously 
shown in lymphocytes (11, 15), autophagic flux was not activated 
in neutrophils from diseased MRL/lpr mice. Accordingly, P140 
did not affect expression of autophagy markers as compared to 
ScP140.
DiscUssiOn
Many aspects of neutrophil biology have been implicated in 
the pathogenesis of SLE (4). Especially the formation of NETs 
has been in the center of research during the last years (26–30). 
Typical during PMA-induced NETosis is the generation of 
many vesicles before plasma membrane rupture (16, 31). These 
vesicles have a double phospholipid bilayer and are believed to 
originate from the nuclear envelope, which disintegrates during 
NET formation. Finally, but still before plasma membrane per-
meabilization, nuclear chromatin decondenses and mixes with 
the contents of the granules; this is essential for formation of 
functional NETs. These arguments led us to examine if P140/
Lupuzor™, a molecule that was shown to modulate autophagy 
in lymphocytes, could also alter NET formation or other aspects 
of neutrophil function, such as ROS production and the release 
of inflammatory mediators, which are important in both certain 
kinds of NET formation and the pathogenesis of lupus (31–33).
At this stage, however, our experimental data do not allow us 
to endorse this idea, at least in the experimental setting used in 
this study (namely, with diseased lupus mice). Treatment with 
P140 did not induce production by PMNs of ROS, cytokines, 
or chemokines and did not modulate NET formation in in vitro 
and in vivo assays. Consequently, a connection between CMA or 
macroautophagy and neutrophil functions cannot be drawn, in 
contrast to B lymphocytes, in which P140 modulates autophagy 
(11, 34). Several possible explanations can be put forward to 
explain this lack of effect.
First, and most importantly, we did not observe an increase 
of autophagic flux in neutrophils from diseased mice, which 
explains the lack of P140 activity in this cell type, because P140 
9Maueröder et al. Autophagy and NET Formation
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 8 | Article 16
is active under conditions of autophagic flux only. Second, no 
active flux in splenocytes of starved C3H mice could be visual-
ized. It is widely accepted that autophagy is activated in response 
to nutrient deprivation in a variety of cell types. However, it has 
to be mentioned that when animals are starved, effects are more 
particularly observed in organs like the liver as compared to 
immune cells, and this feature could explain our results. Third, 
the in vivo administration protocol of P140 chosen in the present 
work could have influenced the results. An effect of P140 on 
autophagy markers in MRL/lpr splenocytes was visualized 5 days 
FigUre 7 | effect of P140 on autophagy in isolated splenic neutrophils. Similar experiments were performed as in Figures 5 and 6, but with isolated splenic 
neutrophils instead of total splenoctes. (a) Immunoblots of microtubule-associated-protein light chain 3b (MAP1LC3B), SQSTM1, HSPA8, and ATG12/5 antibodies 
with three independent mice for control peptide scrambled P140 (ScP140) and two for P140 peptide. The expression levels were quantified by densitometry and 
normalized to ACTB/β-actin. For MAP1LC3B-II, autophagic flux was measured by dividing the values of MAP1LC3B-II with lysosomal protein inhibitor by those of 
MAP1LC3B-II without lysosomal protein inhibitor. (B) Histogram representation of immunoblots from Figure 7a. nt, not tested.
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